August 6, 2020

The Niche

Knoepfler lab stem cell blog

Month: February 2020

5 min read

Today I’m posting about pet peeves in the science lab. This is an update to and expansion of a post from many years ago. Who doesn’t have some lab pet peeves? And, yeah, we are all probably guilty at one time or another of driving other people a bit nuts with our own idiosyncrasies that are their pet peeves. This post is another in my “Elephant in the Lab” series about difficult, but important science topics. We need to discuss these, but they are often uncomfortable so …Read More

4 min read

What’s on your weekend reads list including stem cell papers? In addition to hard-core research papers, I find some bigger picture publications to be helpful too. Then there are just fun items. Every so often I do a post about things that I’m hoping to find time to read over the weekend or that I’ve recently read. Today’s post is one of those items and here are some interesting science reads related in particular to stem cells, cancer, and CRISPR. Stem cell research and …Read More

3 min read

Could stem cells help patients with the novel coronavirus disease COVID-19? It’s hard to say at this point. Is it worth doing trials during the outbreak to find out? Three new clinical studies have popped up on Clinicaltrials.gov investigating the potential of stem cells to help patients infected with the new coronavirus 2019-nCoV. Update, the number of trials on Clinicaltrials.gov is now five as of March 1, 2020. These stem cell COVID-19 studies are part of a tally of 80 or more new clinical …Read More

6 min read

People ask me questions about stem cells all the time so I decide to do a new blog series answering your questions. Today’s post is  the first in this new stem cell Q&A series. Past series have included my Elephant in the Lab series that provides some insights into the craziness that sometimes goes on in academic research with sometimes biting science humor. I’ve also gotten many great questions on my Reddit AMAs both about stem cells and CRISPR. I’m focusing today on a …Read More